New investments for Xpan Inc. and Nanology Labs
FACIT, a commercialization venture firm which funds Ontario oncology innovations, has announced new follow-on investments for two Toronto start-ups - Xpan Inc. and Nanology Labs. Both companies have previously received funding through FACIT’s proof-of-concept Prospects Fund.